Novel research discoveries in multiple sclerosis!

The 7th annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2022 took place February 24-26 in West Palm Beach, FL.
Themed Biomarkers in MS, the meeting brought together experts to share the latest scientific discoveries in the field of MS.

Explore our coverage from the meeting below!

View all videos

ACTRIMS Forum 2022

West Palm Beach, FL, 24-26 February 2022

ACTRIMS Forum 2022

West Palm Beach, FL, 24-26 February 2022

Novel research discoveries in multiple sclerosis!

The 7th annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2022 took place February 24-26 in West Palm Beach, FL.
Themed Biomarkers in MS, the meeting brought together experts to share the latest scientific discoveries in the field of MS.

Explore our coverage from the meeting below!

View all videos

What's new?

View all
2:07
What is the latest progress in gene research in MS?
Lars Alfredsson • 25 Feb 2022
1:10
The potential of non-invasive brain stimulating therapies in negating the adverse symptoms of MS
Leigh Charvet • 26 Feb 2022
3:06
Potential of evobrutinib to target progressive MS
Jorge Alvarez • 25 Feb 2022
1:01
Metformin – a means to promote remyelination in the ageing MS population?
Jason Plemel • 25 Feb 2022

Biomarkers

View all
1:53
Diagnostic potential of paramagnetic rim lesions in MS
Pascal Sati • 26 Feb 2022
4:19
Evaluation of sNfL in MS patients with NEDA-3
Virginia Meca-Lallana • 28 Feb 2022
10:29
Toxic astrogliosis in MS – precision, biomarker-guided combination therapies
Ruturaj Masvekar • 28 Feb 2022
3:56
Imaging biomarkers of RIS
Jiwon Oh • 25 Feb 2022

NMOSD

View all
2:06
Clinical and radiological features of NMOSD
Amy Kunchok • 25 Feb 2022
1:39
Recent progress and future needs in NMOSD treatment
Michael Levy • 25 Feb 2022
10:36
SPHERES: collecting real-world data to explore disease characteristics & clinical outcomes in NMOSD
Brian Weinshenker et al. • 28 Feb 2022
2:50
Chronic cognitive impairment improved after eculizumab initiation in cases of NMOSD
Dalia Rotstein • 25 Feb 2022

Genetics

View all
1:53
CNS gene expression identified as a critical determinant of MS severity
Adil Harroud • 25 Feb 2022
1:34
Genetic biomarkers of MS susceptibility and the gut microbiome
Mitzi Joi Williams • 25 Feb 2022
2:57
The clinical presentation of MS in Latin American populations
Victor Rivera • 24 Feb 2022
4:10
Environmental interactions in multiple sclerosis according to DRB1 hetero-homozygosity
Lars Alfredsson • 25 Feb 2022
The content of VJNeurology is intended for healthcare professionals